Anti-infective Drugs Market Share

Statistics for the 2023 & 2024 Anti-infective Drugs market share, created by Mordor Intelligence™ Industry Reports. Anti-infective Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Active Pharmaceutical Ingredients Research General Pharmaceuticals Research Anti-infectives Research Anti-infective Agents Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Anti-infective Drugs Industry

The anti-infective drugs market is competitive and consists of many global and local players. The market participants are actively launching new products and obtaining approvals for them, which is anticipated further to intensify the competitive environment within the studied market. Some key players in the anti-infective drugs market are Novartis AG, Merck & Co., Inc, Sanofi SA, GSK, and Gilead Sciences, among others.

Anti Infective Drugs Market Leaders

  1. Merck & Co., Inc

  2. Gilead Sciences

  3. GlaxoSmithKline PLC

  4. Pfizer Inc

  5. Novartis AG

*Disclaimer: Major Players sorted in no particular order

Anti-infective Drugs Market Concentration

Anti Infective Drugs Market Report Snapshots

Anti Infective Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)